Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy

PURPOSE: Triple-negative breast cancer (TNBC) is more than a single disease. Identifying biomarkers to further subdivide TNBC patients with distinct outcome is of great importance. It has been reported that single-nucleotide polymorphisms (SNPs) in Aurora kinase A (AURKA) or Aurora kinase B (AURKB)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yuqian, Liao, Yulu, Li, Jun, Li, Junyu, Fan, Ying, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159783/
https://www.ncbi.nlm.nih.gov/pubmed/30288111
http://dx.doi.org/10.2147/CMAR.S174735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159783/
https://www.ncbi.nlm.nih.gov/pubmed/30288111
http://dx.doi.org/10.2147/CMAR.S174735

Ejemplares similares